D-Trp-Aib
D-Trp-Aib is a dipeptide and amyloid-β inhibitor with a Kd of 29.6 nM. D-Trp-Aib triggers formation of non-toxic, non-β-sheet, amorphous amyloid β clusters from misfolded amyloid β monomers and toxic amyloid β oligomers, and reduces toxic amyloid β1-42 deposits. D-Trp-Aib inhibits amyloid fibril formation of α‑synuclein, IAPP and calcitonin. D-Trp-Aib can be used for the research of Alzheimer's disease.
연구목적의 판매만을 진행합니다. 환자를 대상으로 한 판매는 하지 않습니다.
- CAS No.: 1123071-24-8
- 화학식: C15H19N3O3
- 분자량:289.34
-
보관:
Please store the product under the recommended conditions in the Certificate of Analysis.
All α-synuclein Isoforms
More
Biological Activity
제품 설명
In Vitro
D-Trp-Aib (Compound 1) binds to Aβ1-42 with an Kd of 29.6 ± 1.7 nM[1].
D-Trp-Aib triggers the formation of larger, non-toxic amorphous and globular clusters from Aβ1-42[1].
D-Trp-Aib partially prevents Aβ1-42-induced membrane potential depolarization[1].
D-Trp-Aib (0.1 nM-1 μM; 90 min) reverses Aβ1-42-induced LTP deficits in mouse hippocampal slices[1].
D-Trp-Aib (molar ratio 1:10-1:30, 50 h) inhibits amyloid fibril formation of α‑synuclein, IAPP and calcitonin, and disassembles preformed amyloid fibrils[2].
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only. Further protocols information, click here.
In Vivo
D-Trp-Aib (0.5-2.0%; eye drops; three times daily; 1 month) reduces toxic amyloid β1-42 deposits and associated complement component C3b inflammation in the retina of an aged AMD mouse model[1].
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.
-
Animal Model:C57BL/6 (5-6 months old; age-related macular degeneration genetic model)[1]
-
Dosage:0.5%; 2.0%
-
Administration:eye drops; three times daily; 3 months
-
Result:Caused a significant reduction in retinal amyloid β1-42 levels compared to vehicle-treated mice.
Produced a greater reduction in retinal amyloid β1-42 levels at 2.0% dose than at 0.5% dose.
-
Animal Model:C57BL/6 (24 months old; aged age-related macular degeneration model)[1]
-
Dosage:0.5%; 2.0%
-
Administration:eye drops; three times daily; 1 month
-
Result:Reduced thick, linear amyloid β1-42 deposits along the Bruch's membrane to isolated, non-toxic aggregates, with no amyloid β1-42 staining in the retinal pigment epithelium.
Induced a corresponding colocalized reduction in C3b (a marker of amyloid β-induced inflammation) compared to controls.
Chemical Information
-
CAS No. 1123071-24-8
-
분자량 289.34
-
화학식 C15H19N3O3
-
SMILES
C([C@H](C(NC(C(O)=O)(C)C)=O)N)C=1C=2C(NC1)=CC=CC2
-
선적
Room temperature in continental US; may vary elsewhere.
-
보관
Please store the product under the recommended conditions in the Certificate of Analysis.
Protocol
-
Amyloid: Congo Red Amyloid Staining
Congo red amyloid staining is a histochemical method used to detect extracellular amyloid deposits in tissue sections based on the affinity of Congo red dye for β-pleated sheet-rich protein aggregates. When bound to amyloid, Congo red produces characteristic apple-green birefringence under polarized light microscopy, which is widely regarded as a diagnostic feature of amyloid deposition in histopathology. The diagnostic principle relies on the combination of dye binding (congophilia) and optical anisotropy under polarized illumination, which distinguishes amyloid from most non-amyloid eosinophilic extracellular deposits in routine histological evaluation. Amyloid identification by Congo red staining remains a cornerstone in diagnostic pathology despite the availability of adjunct methods such as immunohistochemistry and mass spectrometry, particularly because of its ability to localize deposits directly within tissue architecture. The specificity of Congo red-positive deposits is incre
-
Alzheimer’s Disease Modeling
Alzheimer’s Disease (AD) is a neurodegenerative disorder characterized by a progressive decline in cognitive functions and loss of specific types of neurons and synapses. Alzheimer's symptoms can be simulated in mice by injecting drugs (such as Aβ) or genetically modified.
순도&문서
References
Calculators
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)